These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11081450)

  • 1. Chemotherapy versus palliative care in non-small cell lung cancer.
    Nicum S; Cullen MH
    Anticancer Drugs; 2000 Sep; 11(8):603-7. PubMed ID: 11081450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
    Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
    Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
    Cullen MH; Billingham LJ; Woodroffe CM; Chetiyawardana AD; Gower NH; Joshi R; Ferry DR; Rudd RM; Spiro SG; Cook JE; Trask C; Bessell E; Connolly CK; Tobias J; Souhami RL
    J Clin Oncol; 1999 Oct; 17(10):3188-94. PubMed ID: 10506617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
    Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
    J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer.
    Malayeri R; Pirker R; Huber H
    Onkologie; 2001 Oct; 24(5):416-21. PubMed ID: 11694767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Cullen MH
    Lung Cancer; 1995 Apr; 12 Suppl 1():S95-106. PubMed ID: 7551939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S; Fukuoka M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
    Kawahara M
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups.
    Crinò L
    Ann Oncol; 1995; 6 Suppl 3():S45-7. PubMed ID: 8616115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.
    Woods RL; Williams CJ; Levi J; Page J; Bell D; Byrne M; Kerestes ZL
    Br J Cancer; 1990 Apr; 61(4):608-11. PubMed ID: 1691921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
    Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
    Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
    Numico G; Russi E; Merlano M
    Lung Cancer; 2001 Jun; 32(3):213-26. PubMed ID: 11390003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for stage IV non-small cell lung cancer.
    Bitran JD; Vokes EE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1159-68. PubMed ID: 1704879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
    Johnstone DW; Byhardt RW; Ettinger D; Scott CB
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.